Skip to main content

Table 2 Multivatiate analysis for disease-free and overall survival in our included studies

From: Prognostic significance of glypican-3 in hepatocellular carcinoma: a meta-analysis

Study (Reference) Multivariate analysis DFS OS
HR 95% CI P HR 95% CI P
Shirakawal18 Yes NA NA NA 1.84 1.04-3.25 0.034
Yorita19 Yes 3.6 1.8-7.1 0.0003 1.9 0.7-5.1 0.176
Su20 Yes NA NA NA 1.905 1.063-3.415 0.030
Yu21 NA NA NA NA NA NA NA
Wang23 NA NA NA NA NA NA NA
Chen24 Yes 2.27 1.14-4.51 0.02 NA NA NA
Fu25 Yes 2.14 1.39-3.29 0.001 2.29 1.35-3.89 0.002
Liang26 NA NA NA NA NA NA NA
  1. NA, not available; OS, overall survival; DFS, disease-free survival. Hazard ratio (HR); Odds ratio (OR); confidence intervals (CIs).